(5-Chloro-6-(2-methyl-1H-imidazol-1-yl)pyridin-3-yl)boronic acid

Catalog No. :
ACLEUG567
CAS No. :
2225178-83-4
Molecular Formula :
C9H9BClN3O2
Molecular Weight :
237.46

IUPAC Name:(5-chloro-6-(2-methyl-1H-imidazol-1-yl)pyridin-3-yl)boronic acid

(5-Chloro-6-(2-methyl-1H-imidazol-1-yl)pyridin-3-yl)boronic acid structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
No pack options available.

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product Name(5-Chloro-6-(2-methyl-1H-imidazol-1-yl)pyridin-3-yl)boronic acid
IUPAC Name(5-chloro-6-(2-methyl-1H-imidazol-1-yl)pyridin-3-yl)boronic acid
Molecular FormulaC9H9BClN3O2
Molecular Weight237.46
SMILESOB(C1=CC(Cl)=C(N2C=CN=C2C)N=C1)O
InChI KeyAIRHLILKGPJXRN-UHFFFAOYSA-N
Synonym5-Chloro-6-(2-methylimidazol-1-yl)pyridine-3-boronic acid;Boronic acid, B-[5-chloro-6-(2-methyl-1H-imidazol-1-yl)-3-pyridinyl]-;B-[5-Chloro-6-(2-methyl-1H-imidazol-1-yl)-3-pyridinyl]boronic acid
CAS No.2225178-83-4

Safety Data

Pictogram
Harmful or irritant
Signal Word
Achtung
Hazard Statement(s)
H302-H315-H319-H335
Precautionary Statement(s)
P261-P264-P270-P271-P280-P301+P312-P302+P352-P304+P340-P305+P351+P338-P330-P332+P313-P337+P313-P362-P403+P233-P405-P501

Synthetic Route by SureRoute

1. ACLEUG567 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. ACCNFA526 route compound structure diagram
    --
  2. Plus
  3. ACGQCJ379 route compound structure diagram
    ACGQCJ3791072944-15-0 In Stock
  4. Then
  5. ACLEUG567 route product structure diagram
    ACLEUG5672225178-83-4
Inquiry

2. ACLEUG567 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. ACCNFA526 route compound structure diagram
    --
  2. Plus
  3. ACYLFO654 route compound structure diagram
    ACYLFO6541366482-32-7 In Stock
  4. Then
  5. ACLEUG567 route product structure diagram
    ACLEUG5672225178-83-4
Inquiry

Comments (0)